Azithromycin and Bronchial secretion retention - a phase IV clinical study of FDA data

Summary:

Bronchial secretion retention is reported as a side effect among people who take Azithromycin (azithromycin), especially for people who are female, 60+ old, also take Spiriva, and have Asthma.

The phase IV clinical study analyzes which people have Bronchial secretion retention when taking Azithromycin. It is created by eHealthMe based on reports of 38,326 people who have side effects when taking Azithromycin from the FDA, and is updated regularly.

What is Azithromycin?

Azithromycin has active ingredients of azithromycin. It is often used in sinusitis. eHealthMe is studying from 40,716 Azithromycin users. Check the latest studies of Azithromycin.

What is Bronchial secretion retention?

Bronchial secretion retention is found to be associated with 279 drugs and 309 conditions by eHealthMe. Check the latest studies of Bronchial secretion retention.

On Jul, 12, 2026

38,326 people reported to have side effects when taking Azithromycin.
Among them, 69 people (0.18%) have Bronchial secretion retention.

Could Azithromycin cause Bronchial secretion retention?

Among these 69 people:

What is the gender of people who have Bronchial secretion retention when taking Azithromycin? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Bronchial secretion retention when taking Azithromycin? *

What are other drugs people take besides Azithromycin? *

What are other side effects people have besides Bronchial secretion retention? *

Dyspnea (difficult or laboured breathing): 61 people, 88.41%
Cough: 59 people, 85.51%
Sputum Discolored: 54 people, 78.26%
Asthma: 54 people, 78.26%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 54 people, 78.26%
Rales (an abnormal respiratory sound characterized by fine crackles): 54 people, 78.26%
Wrist Fracture: 53 people, 76.81%
Bronchial Wall Thickening: 53 people, 76.81%
Drug Ineffective: 53 people, 76.81%
Upper Limb Fracture: 53 people, 76.81%

What are the existing conditions these people have? *

Asthma: 54 people, 78.26%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 47 people, 68.12%
Cystic Fibrosis (disease of the secretary glands): 6 people, 8.70%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 4.35%
Pseudomonas Bronchitis (bronchitis by bacterium (genus pseudomonas) of a genus that occurs in soil and detritus): 2 people, 2.90%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 1.45%
Meningitis Cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 1 person, 1.45%
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue): 1 person, 1.45%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 1.45%
Bronchial Oedema (build-up of fluid in the bronchia): 1 person, 1.45%

* Approximation only. Some reports may have incomplete information.

Do you take Azithromycin and have Bronchial secretion retention?

- Check whether Bronchial secretion retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azithromycin:

Azithromycin (40,716 reports)

Browse all side effects of Azithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchial secretion retention:

Bronchial secretion retention (279 drugs)

Browse all the conditions that are associated with Bronchial secretion retention:

Bronchial secretion retention (309 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azithromycin (the active ingredients of Azithromycin) and Azithromycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.